Agonist discrimination between AMPA receptor subtypes.
T Coquelle, J K Christensen, T G Banke, U Madsen, A Schousboe, D S Pickering
Index: Neuroreport 11(12) , 2643-8, (2000)
Full Text: HTML
Abstract
The lack of subtype-selective compounds for AMPA receptors (AMPA-R) led us to search for compounds with such selectivity. Homoibotenic acid analogues were investigated at recombinant GluR1o, GluR2o(R), GluR3o and GluR1o + 3o receptors expressed in Sf9 insect cells and affinities determined in [3H]AMPA radioligand binding experiments. (S)-4-bromohomoibotenic acid (BrHIBO) exhibited a 126-fold selectivity for GluR1o compared to GluR3o. Xenopus laevis oocytes were used to express functional homomeric and heteromeric recombinant AMPA-R and to determine BrHIBO potency (EC50) at these channels. (R,S)-BrHIBO exhibited a 37-fold selectivity range amongst the AMPA-R. It is hoped that BrHIBO can be used as a lead structure for the development of other subtype-selective compounds.
Related Compounds
Related Articles:
1981-05-29
[Neurosci. Lett. 23 , 337, (1981)]
1989-10-01
[J. Med. Chem. 32(10) , 2254-60, (1989)]
2005-08-23
[Proc. Natl. Acad. Sci. U. S. A. 102(34) , 12053-8, (2005)]
2001-05-01
[J. Neurosci. 21(9) , 3052-62, (2001)]
1997-11-01
[J. Pharmacol. Exp. Ther. 283(2) , 742-9, (1997)]